CKR-3 Antibodies

Santa Cruz Biotechnology features a diverse variety of CKR-3 monoclonal antibodies for advanced research in cell signaling and receptor biology. CKR-3 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CKR-3, also known as the chemokine receptor 3, plays a crucial role in immune response regulation and is involved in the migration of immune cells to sites of inflammation. Its significance extends to various physiological processes, including hematopoiesis and the development of the central nervous system. Understanding CKR-3 function is essential for elucidating mechanisms underlying immune-related diseases and potential therapeutic targets. CKR-3 monoclonal antibodies enable precise detection and analysis of protein expression patterns across different cell types and tissues. Researchers can investigate cellular localization, protein-protein interactions, and signaling pathways associated with CKR-3. The high specificity of CKR-3 monoclonal antibodies ensures reliable and reproducible results in experimental studies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of chemokine signaling and its impact on human health.